Académique Documents
Professionnel Documents
Culture Documents
Toxic Response
Age
The Precipice
Physiologic Reserves Available
Physiologic Reserves Already In Use
Increasing Age
Masalah Utama
Pilihan obat atau dosis yang tidak tepat Concomitant disease affect metabolism of or response to drug Polypharmacy drug - drug interactions Patient behavioural factors
Perubahan PHARMACOKINETICS
Absorption
active transfer
Body composition
lean body mass body fat plasma albumin
Liver metabolism
oxidation / microsomal enzymes
Renal clearance
Perubahan PHARMACODYNAMICS
Brain sensitivity Benzodiazepines and
Thermoregulation
hypothermia
COMMON PITFALLS 1 :
Gagal mengobati kondisi yang seharusnya bisa diobati (treatable conditions) Thrombolytic therapy
the older the patient, the greater the benefit the older the patient, the less likely to be thrombolysed
Hypertension
30 - 40% decrease in risk of CVA if ISH treated
COMMON PITFALLS 2 :
Prescribing for symptom and not for
diagnosis
PRESCRIPTIONS BY AGE
(Items per person per year)
40 35 30 25 20 15 10 5 0 42 46 50 54 58 62 66 70 74 78 82 86 90
EFFECTIVE PRESCRIBING 1
Utamakan non-pharmalogical treatment
modify diet stop smoking, reduce alcohol physical exercise walking aids, household adaptations social supports
EFFECTIVE PRESCRIBING 2
Treat conditions in order of priority Pertimbangkan kegagalan fungsi organ Start low mulai dosis kecil , naikkan dengan hati-hati Gunakan formularium yang terbatas Monitor compliance and response Review pemakaian obat secara reguler Ikut sertakan PENDERITA
obat bertahan lama di dalam tubuh resiko terkena efek samping obat meningkat
Age-Related Changes:
Total body water menurun konsentrasi dalam darah obat yang larut-air meningkat Perubahan berat badan mempengaruhi dosis yang diperlukan dan lama obat dalam tubuh:
More body fat prolonged half-life Less lean body mass increased drug concentration
Perubahan sistem pencernaan mempengaruhi kecepatan absorbsi obat onset obat lebih lama
Age-Related Changes:
Slower circulation delay drugs getting to liver and kidneys Slow down of liver and kidneys affects time it takes for medication to break down and leave body Less absorption from transdermal patches Drug receptor sites may be different in older adults
Changes in Pharmacokinetics
Perubahan fisiologis dan fungsi organ pada manula perubahan Farmakokinetik Pharmacokinetics is the time course of a drug and its metabolites through the body
Absorption
Distribution Clearance: elimination (renal), metabolism (liver)
Protein Binding
albumin berkurang chronic disease: e.g.,malnutrition, liver or kidney conditions. obat dengan ikatan protein tinggi kadar obat bebas meningkat. ceftriaxone,diazepam, phenytoin, warfarin.
Inducers
Barbiturates Carbamazepine
Azole antifungals
Cimetidine INH
Phenytoin
Rifampin Tobacco
SSRIs
Tacrine
Hepatic Metabolism
Decreased liver size and hepatic blood flow. Regional blood flow to the liver at age 65 is reduce by 40-45% compared to a 25 year old. Metabolic clearance of drugs by the liver may be reduced. Disease effects: liver congestion from heart failure decreases warfarin metabolism and an increased pharmacologic response. Environmental effects: smoking stimulates monoxygenase enzymes and increases clearance of theophylline.
Changes in Pharmacodynamics
Older patients may have more sedation and impaired function after a single dose of benzodiazepines than younger persons. After single dose of nitrazepam older patients made more mistakes on psychomotor testing compared to placebo while younger patients had no impairment .
Suboptimal Quality
Typology of Quality Problems:
Overuse (Polypharmacy) Underuse Misuse (Inappropriate Prescribing) Errors
Suboptimal Prescribing
Polypharmacy Underuse of Effective Medications Drug-Drug Interactions Drug-Disease Interactions Inadequate Monitoring Inappropriate Dosing Inappropriate Duration Drugs to Avoid
Drug-Drug Interactions
Penyebab tersering ESO pada manula Jumlahnya sangat banyak Almost countless peresepan elektronik Some common examples
Statins and erythromycin and other antibiotics TCAs and clonidine or type 1Anti-arrythmics Warfarin and multiple drugs ACE inhibitors increase hypoglycemic effect of sulfonylureas
Drug-disease Interactions
Patient with PD have increased risk of drug induced confusion NSAIA (and COX-2s) s can exacerbate CHF Urinary retention in BPH patients on decongestants or anticholinergics Constipation worsened by calcium, ahticholinergics, calcium channel blockers Neuroleptics and quinolones lower seizure thresholds
Polypharmacy
Polypharmacy = pemberian banyak obat melebihi indikasi penggunaan 59% manula mendapat obat tanpa indikasi yang jelas. 55% manula mendapat obat tanpa indikasi, 32.7% mendapat obat yang tidak efektif, 16.8% mendapat obat duplikasi
2001: Hanlon, JAGS
Underuse
Among patients elderly patients with cardiovascular disease and diabetes, only 19.1% of patients were prescribed statins. In patients 66 to 74 years old, the adjusted probabilities of statin prescription were 37.7%, 26.7%, and 23.4% in the categories of low, intermediate, and high baseline risk, respectively.
The likelihood of statin prescription was 6.4% lower (adjusted odds ratio, 0.94; 95% confidence interval, 0.93-0.95) for each year of increase in age and each 1% increase in predicted 3-year mortality risk. 2004: Ko, JAMA
Inappropriate Prescribing
20-27% manula mendapat resep yang tidak diperlukan (inappropriate). Inappropriate prescribing meningkatkan resiko jatuh, fraktur femur, cognitive impairment, diminished independence, dan mortalitas
a list of medications identified by an expert panel as being inappropriate for older persons because of ineffectiveness or because they pose a high risk for adverse drug events.
Beers MH Arch Intern Med 1997
Menyebabkan timbulnya efek samping obat / adverse drug event (ADE), Mendorong peresepan obat kedua untuk mengatasi ESO sebelumnya
ADE
Drug 2
Extrapyramidal Effects
Levodopa Rx
Avorn J et al, JAMA 1995
In this case, NSAID use increases blood pressure leading to the need for blood pressure lowering therapy.
Blood Pressure
Antihypertensive Rx
In both examples, the initiation of new drug treatments in older persons could have been avoided if there was recognition of the risks of certain drug treatments (e.g. metoclopramide and NSAIDs) in elderly patients.
Gurwitz JH et al, JAMA 1994
Decline in GFR
Decreased effectiveness of diuretics, antihypertensive agents
Drug-Food Interactions
Interactions between drugs and food
warfarin and Vitamin K containing foods (remember green tea, as well) Phenytoin & vitamin D metabolism Methotrexate and folate metabolism
Steroids
Think about osteoporosis prevention Remember steroid induced diabetes
Levothyroxine
Calcium interferes with absorption of levothyroxine
Drug Discrepancies
Difference between medical record and medication bottles in 76% of cases
51% of time medication not recorded 29% medication recorded that patient not taking 20% dosage discrepancy
Nonadherence
Lack of understanding of how to take
High risk times: Hospital discharge, new meds added, complex regimens
Complementary Therapies
Very commonly used in the elderly Some common herbs and alternative therapies:
Anti-aging Dementia BPH OA DHEA, growth hormone Gingko biloba Saw palmetto, PC-SPES Chondroiton sulfate, glucosamine St. Johns wort, SAMe
Depression
Adulterants in Products
California Department of Health Services, Food and Drug Branch
screened 250 Asian herbal products collected from herbal stores in California assayed products using gas chromatography, mass spectrometry, and atomic-absorption techniques Ko, NEJM 1998; 339; 847
32% contained unlabeled medications, 14% mercury, 14% arsenic, 10% lead
Principles (continued)
Pertimbangkan pemakaian kotak obat harian atau mediset Hentikan pemakaian obat yang tidak jelas keuntungannya atau resiko efek sampingnya lebih merugikan Hati-hati pemakaian obat baru (newer drugs) Hindari penggunaan obat > 5 macam Consider if the benefit of the 7th or 8th drug is sufficient to justify the cost, increase in complexity of regimen, and risk of side effects
Newer drugs
What is unique about this compound? What clinical data is available? How does it compare with traditional therapy? How expensive is it? With third party payers cover this product? Does the potential advantage of this new drug justify the risk of using a new drug?